Immunological Memory and Reinfection by SARS-CoV-2/COVID-19

Main Article Content

Angélica Maria Forero Ladino
Paola Rivadeneira Santacruz
Ana Maria Ospina Delgado
Juan Pablo Rojas Hernandez

Abstract

Introduction: The severe acute respiratory syndrome caused by Coronavirus 2 (SARS-CoV-2) is a type of coronavirus that causes the coronavirus disease (COVID-19), which has become a significant problem for global public health due to the pandemic and its high transmissibility and mortality. Since the beginning of the SARS-CoV-2 / COVID-19 pandemic, multiple questions have been generated, such as the production of immunological memory and the appearance of cases of reinfection by the same virus.


Objective: Review the microbiological and clinical characteristics, immunological memory, and reinfection by SARS-CoV-2.


Conclusions: The infection by SARS-CoV-2 in patients with mild disease has been associated with protective immunity for a limited time, which could explain the presentation of cases of reinfection after the initial event with a demonstration of the production of Immunoglobulin G antibodies (IgG).

Downloads

Download data is not yet available.

Article Details

How to Cite
Forero Ladino, A. M., Rivadeneira Santacruz, P. ., Ospina Delgado , A. M. ., & Rojas Hernandez , J. P. . (2023). Immunological Memory and Reinfection by SARS-CoV-2/COVID-19. Pediatría, 56(3), e295. https://doi.org/10.14295/rp.v56i3.295
Section
Review topics

References

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. DOI: https://doi.org/10.1056/NEJMoa2001017

Ramiro-mendoza MS. Epidemiología del SARS-CoV-2 Epidemiology SARS-CoV-2. Acta Pediatr Mex. 2020;41(Supl 1):8–14. DOI: https://doi.org/10.18233/APM41No4S1ppS8-S142051

Chen Y, Liu Q, Guo D. Emerging coronaviruses : Genome structure, replication , and pathogenesis. J Med Virol. 2020;92(January):418–23. DOI: https://doi.org/10.1002/jmv.25681

Pastrian-Soto G. Bases Genéticas y Moleculares del COVID-19 (SARS-CoV-2). Mecanismos de Patogénesis y de Respuesta Inmune. Int J Odontostomatol. 2020;14(3):331–7. DOI: https://doi.org/10.4067/S0718-381X2020000300331

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr;181(2):271-280.e8. DOI: https://doi.org/10.1016/j.cell.2020.02.052

Rodda LB, Netland J, Shehata L, Pruner KB, Morawski PA, Thouvenel C, et al. Functional SARS-CoV-2-specific immune memory persists after mild COVID-19. Cell. 2020;(November):1–56. DOI: https://doi.org/10.1101/2020.08.11.20171843

Morris A, Wells A, Wheeler SE. Assessing Immune Response to SARS-CoV-2 Infection. Inmuno Target Ther. 2020;9:111–4. DOI: https://doi.org/10.2147/ITT.S264138

Biron CA. More things in heaven and earth: Defining innate and adaptive immunity. Nat Immunol. 2010;11(12):1080–2. DOI: https://doi.org/10.1038/ni1210-1080

Slifka MK, Ahmed R. Long-term antibody production is sustained by antibody-secreting cells in the bone marrow following acute viral infection. In: Annals of the New York Academy of Sciences. Blackwell Publishing Inc.; 1996. p. 166–76. DOI: https://doi.org/10.1111/j.1749-6632.1996.tb52958.x

Sette A, Crotty S. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns. Nat Rev Immunol. 2020;20(8):457–8. DOI: https://doi.org/10.1038/s41577-020-0389-z

Ortega E. Is Immunological Memory a Burden in Times of COVID-19? Vol. 41, Trends in Immunology. 2020. DOI: https://doi.org/10.1016/j.it.2020.08.004

López Pérez GT, Ramírez Sandoval M de LP, Torres Altamirano MS. Participantes de la respuesta inmunológica ante la infección por SARS-CoV-2. Alergia, Asma e Inmunol Pediátricas. 2020;29(1):5–15. DOI: https://doi.org/10.35366/93321

Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med. 2020 May;382(21):1969–73. DOI: https://doi.org/10.1056/NEJMp2005630

Patel A, Dong JC, Trost B, Richardson JS, Tohme S, Babiuk S, et al. Pentamers not found in the universal proteome can enhance antigen specific immune responses and adjuvant vaccines. Plos One. 2012;7(8):1–12. DOI: https://doi.org/10.1371/journal.pone.0043802

Wajnberg A, Amanat F, Firpo A, Altman D, Bailey M, Mansour M, et al. Title: SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months. 2020. DOI: https://doi.org/10.1101/2020.07.14.20151126

Rodriguez-morales AJ, Cardona-ospina JA, Villamil-gómez WE. Should we concern about reinfection in COVID-19 ? 2020;25(2):77–8. DOI: https://doi.org/10.22354/in.v25i2.922

Prado B, Becerra M, Guadalupe JJ, Barragan V. A case of SARS-CoV-2 reinfection in Ecuador. Lancet Infect Dis. 2020;2(20):30910.

Yagleiry J, Rodríguez M, Merchán JT, García EO, Elena L, Binaghi C, et al. Tratamiento para COVID 19. Rev Latinoam Infectología Pediátrica. 2020;33:42–51. DOI: https://doi.org/10.35366/96670

KK-W, Hung IF-N, Ip JD, Chu AW-H, Chan W-M, Tam AR et al. Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing. Clin Infect Dis. 2020;1–6.

Iwasaki A. What reinfections mean for COVID-19. Lancet Infect Dis. 2020;2(20):19–20.

Julieta K, Domínguez R, Gabriela E, Rodríguez S, Mejía WM, Jiménez AO, et al. Infectología Pediátrica. Rev Latinoam Infectología Pediátrica. 2020;33:10–32. DOI: https://doi.org/10.35366/96666

Guo CX, He L, Yin JY, Meng XG, Tan W, Yang GP, et al. Epidemiological and clinical features of pediatric COVID-19. BMC Med. 2020;18(1):1–7. DOI: https://doi.org/10.1186/s12916-020-01719-2

Chams N, Chams S, Badran R, Shams A, Araji A, Raad M, et al. COVID-19 : A Multidisciplinary Review. Front Public Heal. 2020;8(July):1–20. DOI: https://doi.org/10.3389/fpubh.2020.00383

Bagheri SH, Asghari A, Farhadi M, Shamshiri AR, Kabir A, Kamrava SK, et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak in Iran. Med J Islam Repub Iran. 2020;34(1):1–7. DOI: https://doi.org/10.1101/2020.03.23.20041889

Asociación-Española-de-Pediatría-(AEP). Documento de manejo clinico del paciente pediátrico con infección por SARS-CoV-2. Manejo clínico del Minist Sanid Español. 2020;53(9):1689–99.

Ivveth M, González R, Elena L, Binaghi C, Chávez MS. Infectología Pediátrica Diagnostic methods. Rev Latinoam Infectología Pediátrica. 2020;33:33–41. DOI: https://doi.org/10.35366/96669

Consenso C, Humberto C, Trujillo S, Eduardo R, Quiroga R, Rodríguez AJ, et al. Consenso colombiano de atencion, diagnostico y manejo de la infeccion por SARS CoV 2/COVID 19 en establecimento de atencion de la salud. Infectio. 2020;1–24. DOI: https://doi.org/10.22354/in.v24i3.851

Similar Articles

<< < 9 10 11 12 13 14 15 16 17 18 > >> 

You may also start an advanced similarity search for this article.